Arbutus Biopharma Corp Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2023-08-03: Form 10-Q; Exhibit 10.3; Description Option Agreement, dated July 10, 2023, by and between Arbutus Biopharma Corporation and J. Christopher Naftzger.
- 2023-08-03: Form 10-Q; Exhibit 10.2; Description Executive Employment Agreement, dated effective as of July 10, 2023, between Arbutus Biopharma, Inc. and J. Christopher Naftzger.
- 2023-08-03: Form 10-Q; Exhibit 10.1; Description Executive Employment Agreement, dated effective as of July 10, 2023, between Arbutus Biopharma, Inc. and Karen Sims, MD, PhD.
- 2023-05-30: Form 8-K; Exhibit 10.1; Description Arbutus Biopharma Corporation 2016 Omnibus Share and Incentive Plan, as supplemented and amended.
| Filed | Form | Exhibit | Description |
|---|
| 2023-08-03 | 10-Q | 10.3 | Option Agreement, dated July 10, 2023, by and between Arbutus Biopharma Corporation and J. Christopher Naftzger |
|---|
| 2023-08-03 | 10-Q | 10.2 | Executive Employment Agreement, dated effective as of July 10, 2023, between Arbutus Biopharma, Inc. and J. Christopher Naftzger |
|---|
| 2023-08-03 | 10-Q | 10.1 | Executive Employment Agreement, dated effective as of July 10, 2023, between Arbutus Biopharma, Inc. and Karen Sims, MD, PhD |
|---|
| 2023-05-30 | 8-K | 10.1 | Arbutus Biopharma Corporation 2016 Omnibus Share and Incentive Plan, as supplemented and amended |
|---|
| 2023-03-02 | 10-K | 10.41 | Form of Arbutus Biopharma Corporation Restricted Stock Unit Agreement. |
|---|